These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31463958)

  • 1. The implanted glucose monitoring system Eversense: An alternative for diabetes patients with isobornyl acrylate allergy.
    Oppel E; Kamann S; Heinemann L; Reichl FX; Högg C
    Contact Dermatitis; 2020 Feb; 82(2):101-104. PubMed ID: 31463958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allergic contact dermatitis caused by isobornyl acrylate in the Enlite glucose sensor and the Paradigm MiniMed Quick-set insulin infusion set.
    Herman A; Baeck M; de Montjoye L; Bruze M; Giertz E; Goossens A; Mowitz M
    Contact Dermatitis; 2019 Dec; 81(6):432-437. PubMed ID: 31385313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse cutaneous reaction to diabetic glucose sensors and insulin pumps: Irritant contact dermatitis or allergic contact dermatitis?
    Herman A; de Montjoye L; Baeck M
    Contact Dermatitis; 2020 Jul; 83(1):25-30. PubMed ID: 32212168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allergic contact dermatitis caused by isobornyl acrylate in OmniPod, an innovative tubeless insulin pump.
    Raison-Peyron N; Mowitz M; Bonardel N; Aerts O; Bruze M
    Contact Dermatitis; 2018 Aug; 79(2):76-80. PubMed ID: 29635853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant positive patch test reactions in FreeStyle-allergic patients sensitized to isobornyl acrylate.
    Dendooven E; Foubert K; Goossens A; Gilles P; De Borggraeve W; Pieters L; Lambert J; Aerts O
    Contact Dermatitis; 2021 Mar; 84(3):166-174. PubMed ID: 32965058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Dexcom glucose monitoring system-An isobornyl acrylate-free alternative for diabetic patients.
    Oppel E; Kamann S; Reichl FX; Högg C
    Contact Dermatitis; 2019 Jul; 81(1):32-36. PubMed ID: 30784093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in adhesive ingredients in continuous glucose monitoring systems may induce new contact allergy pattern.
    Svedman C; Ulriksdotter J; Lejding T; Bruze M; Mowitz M
    Contact Dermatitis; 2021 Jun; 84(6):439-446. PubMed ID: 33421157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contact dermatitis caused by glucose sensors in diabetic children.
    Herman A; Darrigade AS; de Montjoye L; Baeck M
    Contact Dermatitis; 2020 Feb; 82(2):105-111. PubMed ID: 31657469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contact dermatitis from glucose sensors in Spain: A multicentric approach.
    Gatica-Ortega ME; Mowitz M; Pastor-Nieto MA; Navarro-Triviño FJ; Fernández-Redondo V; Hernández-Cano N; Borrego L; Gómez-de-la-Fuente E; Torralba M; Svedman C; Giménez-Arnau A
    Contact Dermatitis; 2021 Nov; 85(5):554-562. PubMed ID: 34185891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further Evidence of Severe Allergic Contact Dermatitis From Isobornyl Acrylate While Using a Continuous Glucose Monitoring System.
    Kamann S; Aerts O; Heinemann L
    J Diabetes Sci Technol; 2018 May; 12(3):630-633. PubMed ID: 29542347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usage of Hydrocolloid-Based Plasters in Patients Who Have Developed Allergic Contact Dermatitis to Isobornyl Acrylate While Using Continuous Glucose Monitoring Systems.
    Kamann S; Heinemann L; Oppel E
    J Diabetes Sci Technol; 2020 May; 14(3):582-585. PubMed ID: 31538817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Isobornyl Acrylate Content in Medical Devices for Diabetes Treatment.
    Kamann S; Oppel E; Liu F; Reichl FX; Heinemann L; Högg C
    Diabetes Technol Ther; 2019 Oct; 21(10):533-537. PubMed ID: 31287728
    [No Abstract]   [Full Text] [Related]  

  • 13. Intense skin reaction to a new glucose monitoring and insulin pump system.
    Hamnerius N; Mowitz M
    Contact Dermatitis; 2020 Dec; 83(6):524-527. PubMed ID: 32666537
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of generalised isobornyl acrylate contact allergy from diabetes pump with Dupilumab.
    Arasu A; Ross G
    Australas J Dermatol; 2022 Feb; 63(1):e91-e93. PubMed ID: 34751430
    [No Abstract]   [Full Text] [Related]  

  • 15. New device, 'old' allergens. Allergic contact dermatitis caused by the Dexcom G7 glucose sensor.
    Mowitz M; Hosseini S; Siemund I; Ulriksdotter J; Svedman C
    Contact Dermatitis; 2024 May; 90(5):495-500. PubMed ID: 38316128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isobornyl Acrylate.
    Aerts O; Herman A; Mowitz M; Bruze M; Goossens A
    Dermatitis; 2020; 31(1):4-12. PubMed ID: 31913984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Freestyle libre 2: The new isobornyl acrylate free generation.
    Oppel E; Kamann S; Heinemann L; Klein A; Reichl FX; Högg C
    Contact Dermatitis; 2020 Nov; 83(5):429-431. PubMed ID: 32542740
    [No Abstract]   [Full Text] [Related]  

  • 18. N,N-dimethylacrylamide-A new sensitizer in the FreeStyle Libre glucose sensor.
    Mowitz M; Herman A; Baeck M; Isaksson M; Antelmi A; Hamnerius N; Pontén A; Bruze M
    Contact Dermatitis; 2019 Jul; 81(1):27-31. PubMed ID: 30773644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allergic contact dermatitis caused by isobornyl acrylate in Freestyle® Libre, a newly introduced glucose sensor.
    Herman A; Aerts O; Baeck M; Bruze M; De Block C; Goossens A; Hamnerius N; Huygens S; Maiter D; Tennstedt D; Vandeleene B; Mowitz M
    Contact Dermatitis; 2017 Dec; 77(6):367-373. PubMed ID: 28804907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unexpected positive patch test reactions to sesquiterpene lactones in patients sensitized to the glucose sensor FreeStyle Libre.
    Herman A; Mowitz M; Aerts O; Pyl J; de Montjoye L; Goossens A; Bruze M; Baeck M
    Contact Dermatitis; 2019 Nov; 81(5):354-367. PubMed ID: 31166016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.